0001127602-24-019835.txt : 20240702 0001127602-24-019835.hdr.sgml : 20240702 20240702160843 ACCESSION NUMBER: 0001127602-24-019835 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240702 DATE AS OF CHANGE: 20240702 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Theagene Jean-Manasse CENTRAL INDEX KEY: 0001969857 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41455 FILM NUMBER: 241095222 MAIL ADDRESS: STREET 1: 500 PLACE D ARMES STREET 2: SUITE 1800 CITY: MONTREAL STATE: A8 ZIP: H2Y 2W2 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MAIA Biotechnology, Inc. CENTRAL INDEX KEY: 0001878313 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 444 WEST LAKE STREET, SUITE 1700 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 312-416-8592 MAIL ADDRESS: STREET 1: 444 WEST LAKE STREET, SUITE 1700 CITY: CHICAGO STATE: IL ZIP: 60606 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-06-30 0001878313 MAIA Biotechnology, Inc. MAIA 0001969857 Theagene Jean-Manasse 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 1 0 Stock Options 3.42 2024-06-30 4 A 0 5728 0 A 2024-06-30 2034-06-30 Common Stock 5728 5728 D The stock options, granted on June 30, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date. /s/ Jean-Manasse Theagene 2024-07-02